![Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram](https://www.researchgate.net/publication/317649147/figure/fig2/AS:614004867227655@1523401576104/Patient-disposition-in-the-full-analysis-set-FAS-and-full-analysis-set-preference-no.png)
Patient disposition in the full analysis set (FAS) and full analysis... | Download Scientific Diagram
![Patient disposition. FAS, full analysis set; SAF, safety analysis set. | Download Scientific Diagram Patient disposition. FAS, full analysis set; SAF, safety analysis set. | Download Scientific Diagram](https://www.researchgate.net/publication/347877274/figure/fig2/AS:1024371401424896@1621240582003/Patient-disposition-FAS-full-analysis-set-SAF-safety-analysis-set.png)
Patient disposition. FAS, full analysis set; SAF, safety analysis set. | Download Scientific Diagram
![Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial](https://www.frontiersin.org/files/Articles/936925/fphar-13-936925-HTML-r1/image_m/fphar-13-936925-t004.jpg)
Frontiers | Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
![Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-022-00503-w/MediaObjects/43018_2022_503_Fig1_HTML.png)
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial | Nature Cancer
![A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006) | Journal of Clinical Oncology A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006) | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2023/jco.2023.41.issue-2/jco.22.00291/20221228/images/large/jco.22.00291ta2.jpeg)
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006) | Journal of Clinical Oncology
![Patient disposition. Full analysis set: patients who received treatment... | Download Scientific Diagram Patient disposition. Full analysis set: patients who received treatment... | Download Scientific Diagram](https://www.researchgate.net/publication/266974573/figure/fig1/AS:295741118533632@1447521585516/Patient-disposition-Full-analysis-set-patients-who-received-treatment-with-the-study.png)
Patient disposition. Full analysis set: patients who received treatment... | Download Scientific Diagram
![Subject disposition. Full analysis set (FAS) = all randomised subjects... | Download Scientific Diagram Subject disposition. Full analysis set (FAS) = all randomised subjects... | Download Scientific Diagram](https://www.researchgate.net/publication/262884185/figure/fig1/AS:272046726840330@1441872402241/Subject-disposition-Full-analysis-set-FAS-all-randomised-subjects-who-received-1.png)
Subject disposition. Full analysis set (FAS) = all randomised subjects... | Download Scientific Diagram
![Participant flow. AE, adverse event; FAS, full analysis set; PPS, per... | Download Scientific Diagram Participant flow. AE, adverse event; FAS, full analysis set; PPS, per... | Download Scientific Diagram](https://www.researchgate.net/publication/306083779/figure/fig1/AS:570084788838401@1512930213366/Participant-flow-AE-adverse-event-FAS-full-analysis-set-PPS-per-protocol-set-SAS.png)
Participant flow. AE, adverse event; FAS, full analysis set; PPS, per... | Download Scientific Diagram
![Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK. - ppt download Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK. - ppt download](https://images.slideplayer.com/16/5029825/slides/slide_8.jpg)
Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK. - ppt download
![Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram](https://www.researchgate.net/publication/51712568/figure/fig3/AS:280374765735962@1443857961681/Patient-disposition-SAF-safety-analysis-set-FAS-full-analysis-set-PPS-per-protocol.png)
Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram
![Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/c0a81b87-8ceb-4bbf-a493-55c6d4121bf6/gr1_lrg.jpg)
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
![Flow of patients through the study. FAS, full analysis set; PPS, per... | Download Scientific Diagram Flow of patients through the study. FAS, full analysis set; PPS, per... | Download Scientific Diagram](https://www.researchgate.net/publication/303040724/figure/fig1/AS:565258340311040@1511779498368/Flow-of-patients-through-the-study-FAS-full-analysis-set-PPS-per-protocol-set-SS.png)
Flow of patients through the study. FAS, full analysis set; PPS, per... | Download Scientific Diagram
![Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study | Pediatric Rheumatology | Full Text Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study | Pediatric Rheumatology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12969-016-0106-4/MediaObjects/12969_2016_106_Fig1_HTML.gif)
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study | Pediatric Rheumatology | Full Text
![Definition of the analyzed populations. FAS = full analysis set; PP =... | Download Scientific Diagram Definition of the analyzed populations. FAS = full analysis set; PP =... | Download Scientific Diagram](https://www.researchgate.net/publication/325138414/figure/fig3/AS:626359730724864@1526347205934/Definition-of-the-analyzed-populations-FAS-full-analysis-set-PP-per-protocol.png)